Ledger.Open graph →

SEC Form D · filed March 10, 2021

MapLight Therapeutics, Inc

Offering

$60.0M

Sold

$30.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SAN FRANCISCO, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

George A. Pavlov · San Francisco, CADirector Christopher A. Kroeger · Marlborough, MAExec · Director Robert A. Malenka · San Francisco, CADirector Anatol A. Kreitzer · San Francisco, CAExec Peter A. Bisgaard · Lexington, MADirector Jonathan A. Gillis · San Francisco, CAExec James A. Lillie · San Francisco, CAExec Arad Yedidia · NEW YORK, NYExec Chad Habeeb · Arlington, VAExec · Director Veery C. Maxwell · SAN FRANCISCO, CADirector Saloni C. Multani · SAN FRANCISCO, CADirector Cliff Ryan · SAN FRANCISCO, CAExec Paul Mckenzie · GRAND JUNCTION, CODirector Darren Stainrod · Grand Cayman, Cayman IslandsExec · Director Kevin O'Sullivan · Dublin, IrelandDirector Allison Lomax · George Town, Cayman IslandsDirector Hans Markvoort · Pfaeffikon, V8Director Geoffrey Mattus · Toronto, Ontario, CanadaExec Gary Berman · Toronto, Ontario, CanadaExec Anatol A. Kreitzer · San Francisco, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗